Top Pharma and FMCG Firms in Talks to Acquire Wellbeing Nutrition at INR 15,000-16,000 Million Valuation.

Wellbeing Nutrition, a company backed by Hindustan Unilever and Fireside Ventures, is reportedly being acquired by top pharma and FMCG firms at a valuation of INR 15,000-16,000 million. Kotak is running the process and companies such as Sun Pharma, USV, Alkem Laboratories, Dabur, Nestle, and Reckitt have been approached. The transaction is expected to happen in two tranches with the buyer getting a majority stake.

Wellbeing Nutrition, a company backed by Hindustan Unilever (HUL) and Fireside Ventures, is reportedly being acquired by top pharma and FMCG firms at a valuation of ₹1,500-1,600 crore. Kotak is running the process, and companies such as Sun Pharma, USV, Alkem Laboratories, Dabur, Nestle, and Reckitt have been approached [1].

The transaction is expected to happen in two tranches, with the buyer getting a majority stake. The company, which sells products like oral thin strips, slow-release capsules, and collagen peptides, has been growing rapidly. As of March 2025, it was valued at around ₹961 crore [1]. It aims for ₹350 crore of revenue in FY26, after closing FY25 at ₹170 crore, and expects to become EBITDA-profitable by FY27 [1].

HUL acquired a minority stake in Wellbeing Nutrition in 2022 and has been supportive of the company's growth. The acquisition comes as several FMCG majors eye new-age brands to attract young customers. Founded by Avnish Chhabria in 2019, Wellbeing Nutrition competes with HUL-backed brands like Oziva, Kapiva, Gynoveda, and Nyumi.

The acquisition process is currently undergoing due diligence, and the transaction is expected to be completed in the coming months. The company has decided against raising more funds from venture capital or private equity firms, believing this strategy will help them tap a larger addressable market [1].

References:
[1] https://www.livemint.com/companies/news/wellbeing-nutrition-acquisition-hindustan-unilever-hul-fireside-ventures-strategic-sale-pharma-companies-fmcg-11756471234640.html